Live Webinar: Accelerate Your Biologic Therapeutic Development with a USP 129-Suitable Automated CE-SDS Platform
December 1, 2021, 8:00 AM PST
visit web site
Dr. Richard Easton, Technical Director of Structural Analysis at BioPharmaSpec, discusses the use of the automated Maurice™ platform to provide capillary electrophoresis-sodium dodecyl sulfate (CE-SDS) data for biosimilar comparability studies and Dr. Chris Heger, Director of Applications Science, Bio-Teche, will discuss characterization of Maurice CE-SDS PLUS for USP <129>suitability.

What you'll learn in this webinar:
- Crucial insights into the structure of mAbs, heavily glycosylated species, and PEGylated species
- Information on size heterogeneity, partial species in mAbs, and other impurities
- Reproducible batch-to-batch comparisons
- A USP <129> suitable CE-SDS method for comparable data, less fragmentation, and low injection-induced variations.